Endometriosis affects 1 in 10 women, yet diagnosis takes nearly a decade, leading to prolonged pain, infertility and organ ...
Puxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed ...
Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...
One of Australia's most common gynecological cancers could be detected sooner and more accurately thanks to a specialized artificial intelligence (AI) model, new research shows.
Black women tend to get more aggressive uterine cancers than White women. But this is only part of the story, investigators ...
Event to be held via webcast on March 25, 2025 at 4:00 p.m. ETTo highlight differentiated drug discovery capabilities with its Generative ...
PD-1 blockade conferred benefit to certain women with surgically resectable endometrial cancer, findings presented at Society ...
A combination, triplet therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in ...
The following is a summary of “Facilitators and Barriers to Acceptability of a Biopsy-First Approach in the Diagnostic ...
Byline: Umesh Isalkar Poonam was relieved when MRI and PET scans confirmed her endometrial cancer was in the early, ...
H.C. Wainwright says that competitor data demonstrate impressive ORR in endometrial cancer, opening a potential opportunity for NetCure’s ...